Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
KIDS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$16.59 - $32.00
Previous CloseN/A
Volume20.12K
Average Volume (3M)146.19K
Market Cap
$458.35M
Enterprise Value$529.72M
Total Cash (Recent Filing)$70.15M
Total Debt (Recent Filing)$97.17M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Nov 05, 2025EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding25,073,603
10 Day Avg. Volume162,960
30 Day Avg. Volume146,195
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue2.40
Enterprise Value/Gross Profit3.35
Enterprise Value/Ebitda-31.65
Forecast
1Y Price Target
$35.00Price Target Upside91.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Market PositionPhysician feedback for KIDS' products continues to be extremely positive and emphasizes its dominant position in the pediatric orthopedic market.
Strategic InitiativesOrthoPediatrics is expanding its successful playbook to specialty bracing and pediatric orthotics and prosthetics, which could create meaningful synergies with existing surgeon clients.
ValuationKIDS shares trade at 1.7x NTM EV/Sales, below high-growth peers at 5.5x NTM EV/Sales, indicating potential for multiple expansion as growth sustains.
Bears Say
Costs And ProfitabilityThe company is exposed to tariffs which could impact costs and profitability.
Gross MarginGross margin was down 520 bps Y/Y driven by increased international set sales and 7D placements.
RevenueKIDS' 2Q25 revenue and adjusted EBITDA slightly missed consensus.
OrthoPediatrics News
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $16.59 and its highest was $32.00 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $458.35M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Nov 05, 2025 which is in 38 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Aug 05, 2025. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.29 by $0.18.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.25.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 25,073,603 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.29. Following the earnings report the stock price went down -11.342%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$35.00 (91.47% Upside)
$35.00 (91.47% Upside)
Blogger Sentiment
Bullish
KIDS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 13.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $98.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.12%
12-Months-Change
Fundamentals
Return on Equity
-11.49%
Trailing 12-Months
Asset Growth
16.91%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
KIDS Company Deck
KIDS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial and operational performance, including record revenue growth and successful strategic expansions in key market segments such as Scoliosis and OPSB. However, there were challenges such as a decline in gross margin, slower than expected T&D growth, and restructuring charges. Overall, the positive aspects of the company's performance and future outlook significantly outweigh the negatives.View all KIDS earnings summariesKIDS Stock 12 Month Forecast
Average Price Target
$35.00
▲(91.47% Upside)
Technical Analysis
Ownership Overview
32.71% Insiders
15.38% Mutual Funds
24.92% Other Institutional Investors
19.15% Public Companies and
Individual Investors